Skip to main content

Table 1 Selected characteristics from the analytic study sample (n = 669)

From: Exposure to polychlorinated biphenyls and organochlorine pesticides and risk of dementia, Alzheimer’s disease and cognitive decline in an older population: a prospective analysis from the Canadian Study of Health and Aging

Characteristics

Non-demented individuals (n = 513)

Incident cases of dementia (n = 156)

P-value

Age at study entry, y

80.1 ± 6.12

82.4 ± 6.60

< 0.001

Sex, female, n (%)

304 (59.3)

102 (65.4)

0.17

Education, y

10.1 ± 4.1

9.0 ± 4.1

<  0.01

BMI, kg/m2

25.9 ± 4.6

25.4 ± 5.2

0.30

Total lipids, g/L

6.1 ± 1.7

6.0 ± 2.0

0.63

ApoE4 carrier, n (%)

92 (18.0)

39 (25.2)

< 0.05

3MS score at study entry

88 ± 8.4

83 ± 9.8

< 0.001

Residence area, n (% urban)

448 (87.8)

139 (90.3)

0.41

Smoking, n (% yes) a

217 (46.7)

67 (48.6)

0.70

Alcohol drinking, n (% yes)b

176 (37.7)

44 (32.4)

0.26

Vascular score

1.19 ± 0.83

1.26 ± 0.88

0.38

Blood heavy metal concentrations

 Copper, median (IQR), μmol/L

13.0 (12.0–14.0)

13.0 (12.0–14.0)

0.15

 Lead, median (IQR), μmol/L

0.15 (0.11–0.20)

0.14 (0.10–0.20)

0.55

 Mercury, median (IQR), nmol/L

3.3 (1.7–5.9)

2.4 (1.1–4.6)

< 0.001

 Zinc, median (IQR), μmol/L

340 (270–460)

345 (270–455)

0.88

  1. Note: BMI body mass index, IQR interquartile range
  2. Study entry was set at the moment of blood collection (n = 112 at CSHA-1 and n = 557 at CSHA-2)
  3. Values are represented as mean ± standard deviation unless mentioned otherwise
  4. P-values were obtained using χ2 test for dichotomous variables and t-tests or non-parametric Wilcoxon rank-sum tests for continuous variables, as applicable
  5. a Indicates ever been smoking regularly (nearly everyday)
  6. b Indicates ever been drinking regularly (once a week)
  7. Information was missing for 35 subjects on BMI (21 for nondemented and 14 for demented subjects); 3 subjects on ApoE4 status (2 for nondemented vs. 1 for demented subjects); 5 subjects on residence area (3 for nondemented vs. 2 for demented subjects); 66 subjects on smoking (48 for nondemented vs. 18 for demented subjects); 66 subjects on alcohol drinking (46 for nondemented vs. 20 for demented subjects); 33 subjects on plasma total lipids (27 for nondemented vs. 6 for demented subjects)